Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2003
03/20/2003US20030054490 Isolated human phosphatase proteins, nucleic acid molecules encoding phosphatase proteins and uses thereof
03/20/2003US20030054488 Goodpasture antigen binding protein
03/20/2003US20030054483 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumors and cell proliferative disorders
03/20/2003US20030054482 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumors and cell proliferative disorders
03/20/2003US20030054481 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054480 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054479 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054478 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054477 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumors and cell proliferative disorders
03/20/2003US20030054476 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumors and cell proliferative disorders
03/20/2003US20030054475 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumors and cell proliferative disorders
03/20/2003US20030054474 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumors and cell proliferative disorders
03/20/2003US20030054473 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumors and cell proliferative disorders
03/20/2003US20030054472 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumors and cell proliferative disorders
03/20/2003US20030054471 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumors and cell proliferative disorders
03/20/2003US20030054470 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumors and cell proliferative disorders
03/20/2003US20030054469 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of tumors
03/20/2003US20030054468 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054467 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054466 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054465 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of tumors
03/20/2003US20030054464 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054462 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054461 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of tumors
03/20/2003US20030054460 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054459 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054457 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of tumors
03/20/2003US20030054455 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of tumors
03/20/2003US20030054452 Lysolipid for use in controlling apoptosis and treating inflammatory and innumological disorders
03/20/2003US20030054450 Regeneration of I kappa B kinase in yeast; obtain nucleotide sequences coding preferential kinase, transform yeast, recover transformed yeast, propagate, induce expression of kinase
03/20/2003US20030054448 T1R taste receptors and genes encoding same
03/20/2003US20030054447 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054446 Novel retina-specific human proteins C7orf9, C12orf7, MPP4 and F379
03/20/2003US20030054445 Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01
03/20/2003US20030054444 Nucleotide sequences coding polypeptide for use in the treatment of aberrant cell propagation and nervous system disorders
03/20/2003US20030054443 Nucleotide sequences coding polypeptide for use in the diagnosis, treatment and prevention of immunological, arthritis, asthma, leukemia, skin and inflammatory bowel diseases
03/20/2003US20030054439 Truncated soluble tumor necrosis factor type-I and type-II receptors
03/20/2003US20030054438 Polypeptide for use in the diagnosis and treatment of cancer
03/20/2003US20030054437 Modulating growth, differentiation, or survival of cells; obtain cells, incubate with modulator, monitor adjustments in cell activity
03/20/2003US20030054436 Staphylococcus aureus polynucleotides and sequences
03/20/2003US20030054418 Nucleotide sequences coding polypeptide for use in diagnosis and treatment of lipid and cancer disorders
03/20/2003US20030054409 Novel complex-forming proteins
03/20/2003US20030054404 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054403 Nucleotide sequences coding membrane protein for use in the treatment, diagnosis and prevention of cancer, nervous system, viral, kidney and inflammatory diseases
03/20/2003US20030054402 Transgenic cells for use in the treatment of immunological and inflammatory disorders
03/20/2003US20030054398 Isolated human aminotransferase proteins, nucleic acid molecules encoding aminotransferase proteins and uses thereof
03/20/2003US20030054395 Isolation of nucleic acids
03/20/2003US20030054392 Expression vector for use in the transfer of genetic information
03/20/2003US20030054391 Nucleotide sequences coding polypeptide for use in biological pest control
03/20/2003US20030054390 Oligonucleotide mediated nucleic acid recombination
03/20/2003US20030054387 Metastasis-associated genes
03/20/2003US20030054386 Method for detecting diseases caused by chromosomal imbalances
03/20/2003US20030054384 Integrated systems and methods for diversity generation and screening
03/20/2003US20030054383 Apparatus for use in the generation of preferential nucleotide sequences
03/20/2003US20030054381 Nucleotide sequences for use in forensics and heredity testing; for use in the diagnosis and treatment of respiratory and blood disorder
03/20/2003US20030054380 Diagnosing long qt syndrome; obtain sample, extract nucleotide sequences, incubate with probe, detect polymorphism, presence of polymorphism indicates long qt syndrome
03/20/2003US20030054374 Nucletide sequences coding membrane protein for use ikn the treatment, diagnosis and prevention of cancer, kidney, connective tissue, reproductive and lung disorders
03/20/2003US20030054372 Method for the determination of a nucleic acid using a control
03/20/2003US20030054370 Systematic discovery of new genes and genes discovered thereby
03/20/2003US20030054367 Method for correlating gene expression profiles with protein expression profiles
03/20/2003US20030054365 MHC class II antigen presenting cells containing oligonucleotides which inhibit Ii protein expression
03/20/2003US20030054364 Generation of preferential nucleotides sequences; obtain nucleotide sequence, delete or insert sequences, incubate with primers, amplify, monitor response to sequence variation
03/20/2003US20030054361 Hybridization of polynucleotides conjugated with chromophores and fluorophores to generate donor-to-donor energy transfer system
03/20/2003US20030054359 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cancer and nervous system disorders
03/20/2003US20030054354 Detection of genes associated with preferential cell responses; obtain cells, incubate with oligonucleotide, monitor cells response, adjustment in cell response indicates modulator
03/20/2003US20030054350 TCF-1 nucleotide sequence variation
03/20/2003US20030054348 Methods of identifying the activity of gene products
03/20/2003US20030054341 Viral nucleotide sequences for use in diagnosis, prevention and treatment of viral diseases
03/20/2003US20030054338 Classification of microorganism; obtain microorganism, extract nucleotide sequences, cut with enzymes, incubate with probe, detect signal, classify microorganisms
03/20/2003US20030054337 Malaria immunogen and vaccine
03/20/2003US20030054334 Medical and diagnostic use of a specific co-activator for human nuclear receptors
03/20/2003US20030054013 Tuberculosis therapy; anticancer agents
03/20/2003US20030054010 Molecular antigen array
03/20/2003US20030054009 Vaccine; inducing immunology response
03/20/2003US20030054008 Mycobacterial proteins, microorganisms producing them and their use for vaccines and for the detection of tuberculosis
03/20/2003US20030054003 Antitumor agents, anticarcinogenic agents
03/20/2003US20030054001 Antibody, antigen complex
03/20/2003US20030054000 Anti-pathogen system and methods of use thereof
03/20/2003US20030053999 Enzyme with xylanase activity
03/20/2003US20030053993 Regeneration of nerve cells
03/20/2003US20030053991 Retinoic acid receptor beta-2, its agonists, and gene theraphy vectors for the treatment of neurological disorders
03/20/2003US20030053990 Virus vectors and methods of making and administering the same
03/20/2003US20030053989 Administering nucleic acid
03/20/2003US20030053988 Genetic engineering; culture product; process control
03/20/2003US20030053987 Synthetic hepatitis c genes
03/20/2003US20030053984 Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins
03/20/2003US20030053978 Antitumor agents
03/20/2003CA2488684A1 Glucosyltransferases which glucosylate abscisic acid
03/20/2003CA2466896A1 Method and diagnosis kit for selecting and or qualitative and/or quantitative detection of cells
03/20/2003CA2461692A1 Use of a protein of the crmp family for treating diseases related to the immune system
03/20/2003CA2460509A1 Synthetic hcv envelope proteins and their use for vaccination
03/20/2003CA2460269A1 Alphavirus replicon vector systems
03/20/2003CA2460117A1 Expression profiling in the intact human heart
03/20/2003CA2460092A1 A method of diagnosis and treatment and agents useful for same
03/20/2003CA2460049A1 Enhanced resolution of tumor metastasis
03/20/2003CA2460025A1 Attenuated bacteria useful in vaccines
03/20/2003CA2459945A1 Methods of screening molecules that are used to prevent cardiovascular diseases
03/20/2003CA2459915A1 Blueberry red ringspot virus, sequences, promoters, and uses thereof
03/20/2003CA2459893A1 Methods and apparatus for conducting multiple measurements on a sample
03/20/2003CA2459806A1 Method for increasing stress tolerance in plants
1 ... 2565 2566 2567 2568 2569 2570 2571 2572 2573 2574 2575 2576 2577 2578 2579 2580 2581 2582 2583 2584 2585 ... 4023